Welcome to LookChem.com Sign In|Join Free
  • or
5-[(2R)-2-hydroxy-2-phenylethanoyl]-3-{[4-(4-methylpiperazin-1-yl)benzoyl]amino}-5,6-dihydropyrrolo[3,4-c]pyrazole-1(4H)-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

827318-96-7

Post Buying Request

827318-96-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

827318-96-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 827318-96-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,7,3,1 and 8 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 827318-96:
(8*8)+(7*2)+(6*7)+(5*3)+(4*1)+(3*8)+(2*9)+(1*6)=187
187 % 10 = 7
So 827318-96-7 is a valid CAS Registry Number.

827318-96-7Downstream Products

827318-96-7Relevant academic research and scientific papers

1,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazoles: Identification of a potent aurora kinase inhibitor with a favorable antitumor kinase inhibition profile

Fancelli, Daniele,Moll, Jürgen,Varasi, Mario,Bravo, Rodrigo,Artico, Roberta,Berta, Daniela,Bindi, Simona,Cameron, Alexander,Candiani, Ilaria,Cappella, Paolo,Carpinelli, Patrizia,Croci, Walter,Forte, Barbara,Giorgini, Maria Laura,Klapwijk, Jan,Marsiglio, Aurelio,Pesenti, Enrico,Rocchetti, Maurizio,Roletto, Fulvia,Severino, Dino,Soncini, Chiara,Storici, Paola,Tonani, Roberto,Zugnoni, Paola,Vianello, Paola

, p. 7247 - 7251 (2006)

The optimization of a series of 5-phenylacetyl 1,4,5,6-tetrahydropyrrolo[3, 4-c]pyrazole derivatives toward the inhibition of Aurora kinases led to the identification of compound 9d. This is a potent inhibitor of Aurora kinases that also shows low nanomol

PYRROLO[3,4-c]PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

-

Page/Page column 24, (2008/06/13)

Pyrrolo[3,4-c]pyrazole derivatives of formula (1) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention m

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 827318-96-7